SitesBLAST
Comparing WP_078718069.1 NCBI__GCF_900167125.1:WP_078718069.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P04181 Ornithine aminotransferase, mitochondrial; Ornithine delta-aminotransferase; Ornithine--oxo-acid aminotransferase; EC 2.6.1.13 from Homo sapiens (Human) (see 8 papers)
53% identity, 99% coverage: 4:397/399 of query aligns to 41:436/439 of P04181
- G51 (= G14) to D: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs11553554
- Y55 (= Y18) to H: in HOGA; decreased protein abundance; dbSNP:rs121965037
- N89 (= N52) to K: in HOGA; no effect on protein abundance; dbSNP:rs386833602
- Q90 (= Q53) to E: in HOGA; mistargeted, accumulates in cytoplasm; dbSNP:rs121965060
- C93 (= C56) to F: in HOGA; no effect on protein abundance; dbSNP:rs121965038
- Q104 (= Q67) to R: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833604
- R154 (= R117) to L: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965039
- R180 (= R143) to T: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965040
- A184 (≠ I147) natural variant: Missing (in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965035)
- P199 (= P162) to Q: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs267606925
- A226 (= A188) to V: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965059
- P241 (= P203) to L: in HOGA; no effect on protein abundance; dbSNP:rs121965051
- Y245 (= Y207) to C: in HOGA; no effect on protein abundance; dbSNP:rs121965046
- R250 (= R212) to P: in HOGA; no effect on protein abundance; dbSNP:rs121965052
- T267 (= T229) to I: in HOGA; decreased protein abundance; dbSNP:rs386833618
- A270 (≠ G232) to P: decreased protein abundance; dbSNP:rs121965041
- R271 (= R233) to K: in HOGA; no effect on protein abundance; loss of ornithine aminotransferase activity; dbSNP:rs121965042
- K292 (= K254) modified: N6-(pyridoxal phosphate)lysine
- E318 (= E280) to K: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833621
- V332 (= V294) to M: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965047
- G353 (= G315) to D: in HOGA; decreased protein abundance; dbSNP:rs121965053
- G375 (= G337) to A: in HOGA; decreased protein abundance; dbSNP:rs121965045
- C394 (= C355) to R: in HOGA; no effect on protein abundance; dbSNP:rs121965054; to Y: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833597
- L402 (= L363) to P: in HOGA; may affect protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965043
- P417 (= P378) to L: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs121965044
- I436 (≠ L397) to N: in HOGA; loss of protein stability; loss of ornithine aminotransferase activity; dbSNP:rs386833598
Sites not aligning to the query:
- 1:35 modified: transit peptide, Mitochondrion; in renal form
- 437 L → F: in HOGA; likely benign; no effect on protein stability; no effect on ornithine aminotransferase activity; dbSNP:rs1800456
Q6LFH8 Ornithine aminotransferase; PfOAT; Ornithine--oxo-acid aminotransferase; EC 2.6.1.13 from Plasmodium falciparum (isolate 3D7) (see paper)
51% identity, 98% coverage: 4:393/399 of query aligns to 11:403/414 of Q6LFH8
- C154 (≠ I147) modified: Disulfide link with 163, Reversible; mutation to S: Severe reduction in catalytic activity. Does not affect TRX1-mediated activation. Severe reduction in catalytic activity and loss of TRX1-mediated activation; when associated with S-163.
- C163 (≠ A156) modified: Disulfide link with 154, Reversible; mutation to S: No effect on catalytic activity. Requires higher concentrations of TRX1 for activation. Severe reduction in catalytic activity and loss of TRX1-mediated activation; when associated with S-154.
- C316 (≠ I308) mutation to S: About 70% reduction in catalytic activity. Does not affect TRX1-mediated activation.
- C350 (≠ L340) mutation to S: About 70% reduction in catalytic activity. Does not affect TRX1-mediated activation.
- C390 (≠ V380) mutation to S: About 70% reduction in catalytic activity. Does not affect TRX1-mediated activation.
8ez1B Human ornithine aminotransferase (hoat) co-crystallized with its inactivator 3-amino-4-fluorocyclopentenecarboxylic acid (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 8ez1B
- binding (1R,3S,4Z)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic acid: Y48 (= Y48), T104 (≠ S104), G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), E198 (= E197), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254), R376 (= R374)
8ez1A Human ornithine aminotransferase (hoat) co-crystallized with its inactivator 3-amino-4-fluorocyclopentenecarboxylic acid (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 8ez1A
- binding (3E,4E)-4-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-3-iminocyclopent-1-ene-1-carboxylic acid: Y48 (= Y48), G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), E198 (= E197), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254), R376 (= R374)
7tfpC Human ornithine aminotransferase cocrystallized with its inhibitor, (1s,3s)-3-amino-4-(difluoromethylene)cyclopentane-1-carboxylic acid. (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 7tfpC
- binding (1S,3S,4S)-3-amino-4-(fluoromethyl)cyclopentane-1-carboxylic acid: Y18 (= Y18), Y48 (= Y48), F140 (= F140), E198 (= E197), K255 (= K254), R376 (= R374)
- binding pyridoxal-5'-phosphate: G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254)
7lk0A Ornithine aminotransferase (oat) cocrystallized with its potent inhibitor - (s)-3-amino-4,4-difluorocyclopent-1-enecarboxylic acid (ss-1-148) (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 7lk0A
- binding (1R,3S)-3-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]-4-oxocyclopentane-1-carboxylic acid: Y18 (= Y18), Y48 (= Y48), G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), E198 (= E197), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254)
7jx9A The crystal structure of human ornithine aminotransferase with an intermediate bound during inactivation by (1s,3s)-3-amino-4- (hexafluoropropan-2-ylidenyl)-cyclopentane-1-carboxylic acid. (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 7jx9A
- active site: F140 (= F140), E193 (= E192), D226 (= D225), Q229 (= Q228), K255 (= K254), T285 (= T284), R376 (= R374)
- binding (1S,3S,4S)-3-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]-4-(1,1,3,3,3-pentafluoroprop-1-en-2-yl)cyclopentane-1-carboxylic acid: Y18 (= Y18), Y48 (= Y48), G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), E198 (= E197), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254), R376 (= R374)
- binding N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]glycine: S149 (= S149), F163 (= F163), M164 (≠ T164), P165 (= P165), F167 (= F167), R180 (≠ Q180), A181 (= A181)
6v8dA Design, synthesis, and mechanism of fluorine-substituted cyclohexene analogues of gama-aminobutyric acid (gaba) as selective ornithine aminotransferase inactivators
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 6v8dA
- active site: F140 (= F140), E193 (= E192), D226 (= D225), Q229 (= Q228), K255 (= K254), T285 (= T284), R376 (= R374)
- binding (3Z)-3-iminocyclohex-1-ene-1-carboxylic acid: Y48 (= Y48), K255 (= K254)
- binding pyridoxal-5'-phosphate: T104 (≠ S104), G105 (= G105), V106 (≠ A106), W141 (≠ H141), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254)
2canA Human ornithine aminotransferase complexed with l-canaline (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 2canA
- active site: F140 (= F140), E193 (= E192), D226 (= D225), Q229 (= Q228), K255 (= K254), T285 (= T284), R376 (= R374)
- binding canaline: Y18 (= Y18), F140 (= F140), R143 (= R143), G283 (= G282), S284 (= S283)
- binding pyridoxal-5'-phosphate: G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), D226 (= D225), I228 (= I227), Q229 (= Q228), K255 (= K254)
1gbnB Human ornithine aminotransferase complexed with the neurotoxin gabaculine (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 1gbnB
- active site: F140 (= F140), E193 (= E192), D226 (= D225), Q229 (= Q228), K255 (= K254), T285 (= T284), R376 (= R374)
- binding gabaculine: Y18 (= Y18), Y48 (= Y48), F140 (= F140), E198 (= E197), K255 (= K254)
- binding pyridoxal-5'-phosphate: G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), D226 (= D225), I228 (= I227), K255 (= K254)
1gbnA Human ornithine aminotransferase complexed with the neurotoxin gabaculine (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 4:399/402 of 1gbnA
- active site: F140 (= F140), E193 (= E192), D226 (= D225), Q229 (= Q228), K255 (= K254), T285 (= T284), R376 (= R374)
- binding 3-aminobenzoic acid: Y18 (= Y18), Y48 (= Y48), E198 (= E197), K255 (= K254)
- binding pyridoxal-5'-phosphate: G105 (= G105), V106 (≠ A106), F140 (= F140), W141 (≠ H141), D226 (= D225), I228 (= I227), K255 (= K254)
7ta0A Human ornithine aminotransferase (hoat) soaked with 5-aminovaleric acid (see paper)
53% identity, 99% coverage: 4:397/399 of query aligns to 5:400/403 of 7ta0A